AVITA Medical (RCEL) Share-based Compensation (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | AVITA Medical | 121.89 Mn | 103.71 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -50.66% |
| Sep 30, 2025 | 4.27% |
| Jun 30, 2025 | -0.93% |
| Mar 31, 2025 | -3.72% |
| Dec 31, 2024 | -31.42% |
| Sep 30, 2024 | 1.32% |
| Jun 30, 2024 | 55.42% |
| Mar 31, 2024 | 19.35% |
| Dec 31, 2023 | -10.66% |
| Sep 30, 2023 | 112.60% |
| Jun 30, 2023 | -56.70% |
| Mar 31, 2023 | 117.11% |
| Dec 31, 2022 | -15.32% |
| Sep 30, 2021 | 30.64% |
| Jun 30, 2021 | 5.78% |
| Mar 31, 2021 | 285.26% |
| Dec 31, 2020 | -89.41% |
| Sep 30, 2020 | 184.55% |
| Jun 30, 2020 | 57.31% |
| Mar 31, 2020 | -211.68% |
| Dec 31, 2019 | -331.99% |
| Sep 30, 2019 | -218.10% |
| Jun 30, 2019 | 0.35% |
| Mar 31, 2019 | -4.38% |
| Dec 31, 2018 | 173.27% |
| Sep 30, 2018 | 115.62% |